Article

theepochtimes.com on 2023-12-09 02:40

First Time Ever CRISPR Gene-Editing Therapy Approved in the US

Clinical trial findings showed both treatments could reduce pain from vaso-occlusive events, hallmarks of sickle cell disease.

Related news